The arena of idiopathic pulmonary fibrosis (IPF) treatment is witnessing a revolutionary phase with the advent of AI-driven solutions. AI stands as a groundbreaking force in reimagining drug discovery and development processes, taking significant strides in IPF treatment. Rentosertib, discovered
The landscape of medical treatments has experienced a significant development as the FDA has given approval for a new presentation of Celltrion's SteQeyma for pediatric psoriasis and psoriatic arthritis. SteQeyma, an ustekinumab biosimilar referencing Stelara, received authorization for a
Could the future of brain tumor diagnosis truly be in the hands of artificial intelligence? As medical science rigorously explores the confluence of technology and healthcare, AI emerges as a groundbreaking tool in the world of cancer diagnostics. Specifically, this transformative technology
Ivan Kairatov is a renowned expert in biopharma, with a strong track record in research and development, particularly in technological innovations that drive pharmaceutical advancements. With his deep understanding of these domains, Ivan offers insights into groundbreaking studies and developments,
In today's interview, we have the pleasure of speaking with Ivan Kairatov, a biopharma expert renowned for his expertise in technology and innovation within the industry. With extensive experience in research and development, Ivan provides invaluable insights into the current challenges and
In recent years, the aging global population has brought significant attention to age-related health issues, especially sarcopenia—a condition marked by the loss of muscle mass and function. As traditional approaches such as exercise and nutrition struggle to counteract the cellular dysfunctions
